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 ABSTRACT 
Oxidative stress is implicated in the pathogenesis of many human diseases, thus it is 
interesting to study the relationship between antioxidants, the development and 
progression of diseases. The thioredoxin and glutaredoxin systems are ubiquitous redox-
active proteins known to be induced in chronic inflammatory related processes, such as 
cancer and diabetes, to protect against oxidative stress. The thioredoxin system is 
composed of thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH. The 
glutaredoxin system comprises glutathione reductase (GR), glutathione (GSSG/GSH), 
glutaredoxin (Grx) and NADPH. Trx is an important antioxidant and a redox regulator, 
crucial for the activation of transcription factors and modulation of intra- and 
extracellular signaling pathways. While, Grx is another crucial redox regulator with an 
important role in maintaining intracellular GSH-disulfide-dithiol exchange, apoptosis and 
cell differentiation. In fact, Trx, Grx and TrxR have been suggested biomarkers for 
disease monitoring. Thus, there is a current need for new techniques to detect and 
monitor Trx, Grx and TrxR activities in human patient samples; since the traditional 
methods showed several limitations related to background, specificity and sensitivity. 
The aim of this thesis was to develop highly sensitive and reproducible assays to enable 
analysis of Trx, TrxR and Grx activities in clinical patient samples. Thus, we optimized 
the synthesis of two fluorescent substrates, dieosin-diglutathione (Di-E-GSSG) and 
fluorescein labelled insulin (FITC-insulin), which both gave higher fluorescence upon 
disulfide reduction. The latter, FITC-insulin, was used to develop highly sensitive 
microplate assays for Trx (≥ 0.4 picomoles) and TrxR (≥ 40 femtomole). Moreover, this 
method allowed reproducible measurements of re-activated Trx, commonly present in 
frozen or over-oxidized samples from cell, tissue (biopsies) and blood plasma origin 
(manuscript I). The former Di-E-GSSG, was an excellent substrate of Grx and could be 
used to glutathionylate proteins (such as BSA, yielding E-GS-BSA), thus becoming a 
useful fluorescent marker for glutathionylated proteins in gel electrophoresis. This mixed 
disulfide substrate, E-GS-BSA, allowed measurements of Grx1 and Grx2 activities in 
picomole concentrations (manuscript II). E-GS-BSA was further a key substrate for 
reverse-S-glutathionylation catalysis studies, which facilitated the characterization and 
study of the catalytic properties of human recombinant Grx5 (paper IV). In addition, we 
applied these optimized methods to the study of relevant clinical samples from patients 
showing a mutation in the selenocysteine insertion sequence–binding protein 2 gene, 
which lead to a multisystem selenoprotein deficiency disorder. Our measurements of 
TrxR activity in skin biopsies and PBMCs from these patients, showed significant 
decreased TrxR activity and concomitant increased of ROS levels when compared to 
healthy controls (paper III). In conclusion, we present novel sensitive tools to study Trx, 
TrxR and Grx activities in complex samples from biological origin. Since these redox 
enzymes have been suggested as potential biomarkers for several diseases; the actual 
relevance of our newly developed methodologies, goes beyond the enzymatic 
measurements performed, as these methods might assist in detecting and/or analyzing 
disease progression with clear biomedical applications. 
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